>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

Senate bill to increase debt limit could set the stage for five-year SGR freeze: Provisions fall short of medicine’s goal of true reform

Friday, January 29, 2010

On Thursday the Senate passed H.J. Res. 45, a resolution to raise the federal debt limit.  The resolution also included a “PAYGO” provision, meaning that any new spending or tax cuts must be offset by spending cuts or tax increases.  Noteworthy for physicians, H.J. Res. Includes several exemptions from PAYGO rules, including one for a temporary fix to the Medicare Sustainable Growth Rate formula (SGR).

The SGR exemption would allow up to $82 billion in spending for an SGR fix, which would likely translate into a five-year freeze with larger cuts expected thereafter.  Some reports suggest that actual SGR reform provisions will be attached to legislation extending unemployment insurance, expected to be introduced soon.

Without further Congressional action, anesthesiologists and all physicians face a 21 percent Medicare payment cut beginning March 1, 2010, with additional cuts projected in future years. 

Instead of a short-term fix, ASA strongly supports SGR reforms passed by the U.S. House of Representatives as H.R. 3961, the “Medicare Physician Payment Reform Act.”  H.R. 3961 passed the House by a vote of 2430183 on Nov. 19, 2009, and was subsequently placed on the Senate calendar.  This legislation would permanently repeal the unworkable SGR and create a path for future positive updates.

ASA members should call their Senators and ask them to bring H.R. 3961 to the Senate floor, and pass it immediately.  Please click HERE for call instructions and talking points.

« Back to Washington Alerts